CDEK
← All organizations

Accentia Biopharmaceuticals

For profit

Also known as: Accentia | Revimmune

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 1, 2006

Last known activity

Oct 31, 2024

Defunct as of Jun 1, 2013

Timeline

2000s

  1. Jan 1, 2002

    Accentia Biopharmaceuticals— Founded

2010s

  1. Jun 1, 2013

    Accentia Biopharmaceuticals— Defunct

Drugs by trial phase (4 distinct, 13 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

Details

Founded
Tampa, FL, US Jan 1, 2002
Last known activity
Oct 31, 2024